Drug development strategies for the treatment of obesity: how to ensure efficacy, safety, and sustainable weight loss

S Barja-Fernandez, R Leis, FF Casanueva… - Drug Design …, 2014 - Taylor & Francis
The prevalence of obesity has increased worldwide, and approximately 25%–35% of the
adult population is obese in some countries. The excess of body fat is associated with …

[PDF][PDF] Drug development strategies for the treatment of obesity: how to ensure efficacy, safety, and sustainable weight loss

S Barja-Fernandez - Drug Design, Development and Therapy, 2014 - scienceopen.com
The prevalence of obesity has increased worldwide, and approximately 25%–35% of the
adult population is obese in some countries. The excess of body fat is associated with …

[PDF][PDF] Drug development strategies for the treatment of obesity: how to ensure efficacy, safety, and sustainable weight loss

S Barja-Fernandez - Drug Design, Development and Therapy, 2014 - runa.sergas.gal
The prevalence of obesity has increased worldwide, and approximately 25%–35% of the
adult population is obese in some countries. The excess of body fat is associated with …

[PDF][PDF] Drug development strategies for the treatment of obesity: how to ensure efficacy, safety, and sustainable weight loss

S Barja-Fernandez - Drug Design, Development and Therapy, 2014 - runa.sergas.es
The prevalence of obesity has increased worldwide, and approximately 25%–35% of the
adult population is obese in some countries. The excess of body fat is associated with …

[PDF][PDF] Drug development strategies for the treatment of obesity: how to ensure efficacy, safety, and sustainable weight loss

S Barja-Fernandez - Drug Design, Development and Therapy, 2014 - academia.edu
The prevalence of obesity has increased worldwide, and approximately 25%–35% of the
adult population is obese in some countries. The excess of body fat is associated with …

[HTML][HTML] Drug development strategies for the treatment of obesity: how to ensure efficacy, safety, and sustainable weight loss.

S Barja-Fernandez, R Leis, FF Casanueva… - Drug Design …, 2014 - europepmc.org
The prevalence of obesity has increased worldwide, and approximately 25%–35% of the
adult population is obese in some countries. The excess of body fat is associated with …

[PDF][PDF] Drug development strategies for the treatment of obesity: how to ensure efficacy, safety, and sustainable weight loss

S Barja-Fernandez - Drug Design, Development and Therapy, 2014 - researchgate.net
The prevalence of obesity has increased worldwide, and approximately 25%–35% of the
adult population is obese in some countries. The excess of body fat is associated with …

Drug development strategies for the treatment of obesity: how to ensure efficacy, safety, and sustainable weight loss

S Barja-Fernandez, R Leis, FF Casanueva… - Drug Design …, 2014 - go.gale.com
The prevalence of obesity has increased worldwide, and approximately 25%-35% of the
adult population is obese in some countries. The excess of body fat is associated with …

[PDF][PDF] Drug development strategies for the treatment of obesity: how to ensure efficacy, safety, and sustainable weight loss

S Barja-Fernandez - Drug Design, Development and …, 2014 - pdfs.semanticscholar.org
The prevalence of obesity has increased worldwide, and approximately 25%–35% of the
adult population is obese in some countries. The excess of body fat is associated with …

Drug development strategies for the treatment of obesity: how to ensure efficacy, safety, and sustainable weight loss

S Barja-Fernandez, R Leis… - Drug design …, 2014 - pubmed.ncbi.nlm.nih.gov
The prevalence of obesity has increased worldwide, and approximately 25%-35% of the
adult population is obese in some countries. The excess of body fat is associated with …